Expansion of Th1-like Vγ9Vδ2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid

Expansion of Th₁-like Vγ₉Vδ₂T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid

Leukemia. 2017 Jan;31(1):258-262. doi: 10.1038/leu.2016.273. Epub 2016 Oct 4.

¹ Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
² Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima, Japan.
³ Department of Orthodontics and Dentofacial Orthopedics, The University of Tokushima Graduate School of Oral Science, Tokushima, Japan.
⁴ Department of Histology and Oral Histology, The University of Tokushima Graduate School of Oral Science, Tokushima, Japan.
⁵ Department of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
⁶ Fujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima, Japan.

No abstract available